Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

Oncotarget. 2017 Jun 27;8(26):43592. doi: 10.18632/oncotarget.18610.
No abstract available

Publication types

  • Published Erratum